This brand name is authorized in Austria, Brazil, Cyprus, Germany, Estonia, Croatia, Israel, Malta, Nigeria, Netherlands, Poland, Romania, Singapore, Turkey, United States, South Africa
The drug EUTHYROX contains one active pharmaceutical ingredient (API):
1
Levothyroxine
UNII 9J765S329G - LEVOTHYROXINE SODIUM
|
Levothyroxine sodium is used for the treatment of hypothyroidism. The chief action of levothyroxine is to increase the rate of cell metabolism. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
EUTHYROX Tablet | Marketing Authorisation Holder | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
H03AA01 | Levothyroxine sodium | H Systemic hormonal preparations, excl. Sex hormones and insulins → H03 Thyroid therapy → H03A Thyroid preparations → H03AA Thyroid hormones |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 525404125112419, 525404126119417, 525404127115415, 525404128111413, 525404129118411, 525404130116419, 525404131112417, 525404132119415, 525404133115413, 525404134111411, 525404135118312, 525418120050503, 525418120050603, 525418120050703, 525418120050803, 525418120050903, 525418120051003, 525418120051103, 525418120051203, 525418120051303, 525418120051403, 525418120051503 |
Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 01916681, 01916706, 01916729, 02050605, 02050640, 02050692, 02198012, 02292194, 02292202, 02361819, 02754677, 02754708, 02754737, 02754766, 02754795, 02754826, 02754855, 02754861, 02754878, 02754884, 03542291, 03542322, 09714250, 17267210 |
Country: EE | Ravimiamet | Identifier(s): 1102600, 1706352, 1827121 |
Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-012640690, HR-H-049751832, HR-H-261403751, HR-H-303506536, HR-H-531410473, HR-H-628995193, HR-H-853297728, HR-H-867485518 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 8195, 8196, 9422 |
Country: MT | Medicines Authority | Identifier(s): AA565/80601, AA565/80602 |
Country: NG | Registered Drug Product Database | Identifier(s): A4-0147, A4-0160, A4-0161 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 15784, 15792, 23469, 24783, 34894, 48941, 60992, 61018, 90670, 90689, 90697 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100122250, 100122266, 100122303, 100122310, 100122326, 100122332, 100122349, 100122361, 100213454, 100213477, 100213483, 100262725 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W66290002, W66291003, W66292003, W66293002, W66294002, W67515001, W67515002, W67516001, W67516002 |
Country: SG | Health Sciences Authority | Identifier(s): 09739P, 09740P, 09741P, 11536P |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699808010032, 8699808010049, 8699808010056, 8699808010063, 8699808010070, 8699808010087, 8699808010094, 8699808010100 |
Country: US | FDA, National Drug Code | Identifier(s): 72305-025, 72305-050, 72305-075, 72305-088, 72305-100, 72305-112, 72305-125, 72305-137, 72305-150, 72305-175, 72305-200 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 52/21.3/0440, A39/21.3/0401, A39/21.3/0402, A39/21.3/0403 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.